How can healthcare stakeholders positively impact patient behavior?

Insights from global and local industry leaders in Switzerland

Treatment non-adherence is not a new problem on the healthcare agenda. However, it remains an essential one to address. The Swiss team of Observia went on tour to explore the level of awareness and experience with behavioral tools for combating non-adherence.

The team met with 40+ key stakeholders spanning medical, commercial and digital roles from companies across the whole healthcare ecosystem, from pharma to diagnostics and specialty care providers.
Why Switzerland? Because it is a global hub for innovation and an ideal territory to observe new trends in the healthcare sector.
During this tour, we discussed three main subjects: 

  1. Why is the value of patient behavior change often underestimated?
  2. How can pharma lead the way for other actors in healthcare?
  3. Where are we currently on the development timeline?

Want to get the answers? Download and read our newest white paper, providing key insights into the readiness of industry stakeholders to apply behavioral science in patient care. 

“The guidebook content is very informative – I can recognize many themes which are relevant for our company too. The document provides perspectives of various stakeholders in the healthcare ecosystem while also providing reference to specific data points making it trustworthy. I am confident it is as useful for your other contacts in the healthcare industry as it was for me.”

Digital Health Lead for EMEA (Pharma)

Please fill in the form to download Whitepaper :


We are processing this data per your request only. We are hosting the data internally. We will not share it.

Here’s a link to our privacy policy. You can find out how to send a request to access your data, request to delete your data, correct any inaccuracies or restrict our processing of your data.

You have the right to lodge a complaint about the way we handle your data with French Data Protection authority CNIL or you can contact our DPO at contact form for more information or with concerns.

This white paper has been written by Livia Küng, Key Account Director Switzerland at Observia.


See also

Scientific communications

A multiple-cohort analysis of the SPUR 6/24 patient-reported adherence tool


Clinical Ink and Observia: Pioneering Personalized Patient Engagement in Clinical Trials


By your side in 2024: Happy Holidays from Observia!

Accès plateformes